DHSTS Opioid Grant Program

The DHSTS Opioid Grant Program, managed by the New Jersey Department of Health, aims to improve health outcomes for individuals at risk of HIV and STDs due to injection drug use. This funding supports harm reduction services, enhancing access to health and supportive services, and preventing overdose through strategic initiatives at syringe access locations and harm reduction centers. The program seeks to strengthen New Jersey's overall health system and promote healthier communities.

New Jersey Department of Health (NJDOH)
The New Jersey Department of Health leads the state’s response to public health challenges and works to improve health outcomes for all New Jersey residents. Through its three primary branches—Public Health Services, Health Systems, and Integrated Health—the Department collaborates across programs and partners to strengthen New Jersey’s health system. Guided by its mission to protect public health, promote healthy communities, and improve the quality of health care, the Department supports initiatives that advance prevention, system integration, and equitable access to health services statewide.
This funding opportunity supports the delivery of Core Harm Reduction Services and Harm Reduction Health Services for individuals whose behaviors place them at increased risk of HIV and STD transmission due to injection drug use. Funds may be used to strengthen harm reduction and overdose prevention services at syringe access locations, harm reduction centers, and county health departments, with the goal of reducing infectious disease transmission, preventing overdose, and improving access to health and supportive services for vulnerable populations.